Markers of Osteoporosis in Cystic Fibrosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Markers of Osteoporosis in Cystic Fibrosis — Stella

Recruiting

Back to Cystic Fibrosis trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

UT Southwestern Medical Center, Dallas, Texas

Key details

Phase

Post-approval study

Sponsor

University of Texas Southwestern Medical Center

Enrollment target

~100 participants

Started

September 2021

Primary completion

July 2027

Age range

18 Years – 64 Years

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov